KATIE BROWN: Open Payments
NPI 1154602431 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 22 payments from 11 companies in 2025. Trend: 2023 $300 · 2024 $684 · 2025 $502
Food & beverage: $402Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $157 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Biofrontera Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $49 |
| Lilly USA, LLC | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| LEO Pharma Inc. | 1 | $24 |
| Incyte Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: TREMFYA, Sotyktu, SKYRIZI, SPEVIGO, TALTZ, BF-RHODOLED, AMELUZ, OPZELURA.
Industry payments across MT — which companies pay providers there.
